Search

everythinglearnresearchcommunity

for

Search:↓

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

New 5% minoxidil foam effectively promotes hair growth and is safe for use.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Loose anagen hair syndrome, often affecting young girls, can be diagnosed with a hair-pull test and usually gets better on its own, but severe cases may need treatment.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Platelet-rich plasma injections significantly improved hair regrowth and thickness in patients with hair loss.

The man's scalp condition did not improve with tetracycline treatment.

A woman with severe hair loss was successfully treated with the drug adalimumab.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Tofacitinib is an effective and safe treatment for alopecia areata.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

DPCP is effective for treating severe alopecia areata, but relapse is common.

A 7-year-old boy with a brain tumor developed early puberty, which was successfully treated with medication.

Goats infested with lice showed anemia and skin issues, which improved after treatment.

Minoxidil helps hair growth and prevents hair loss in androgenetic alopecia. It's safe and effective.

Higher minoxidil concentration (5%) works better for severe hair loss, with most patients seeing regrowth in 48-60 weeks.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Lipedematous scalp is mainly caused by an increase in fat tissue under the skin and is different from lipedematous alopecia.

Three white adults had a rare scalp condition with increased fat and sometimes hair loss, suggesting it's not limited to black women and might be more widespread.